|
⚲
|
| Keyboard |
| Gergen Mark J
✚
|
|
|---|---|
| CIK # | 0001373110 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001373110] | |
| 4 | [0001373110] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Poseida Therapeutics Inc | |
| Gergen Mark J | |
| Halozyme Therapeutics Inc | |
| Mirati Therapeutics Inc | |
| Amylin Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Poseida Therapeutics Inc PSTX
Employee Stock Option (Right to Buy) · derivative
|
2025-01-08 | Disposed to issuer | 75,000 | $0.00 | |
|
Poseida Therapeutics Inc PSTX
Employee Stock Option (Right to Buy) · derivative
|
2025-01-08 | Disposed to issuer | 342,000 | $0.00 | |
|
Poseida Therapeutics Inc PSTX
Common Stock
|
2025-01-08 | Tender | 636,726 | ||
|
Poseida Therapeutics Inc PSTX
Employee Stock Option (Right to Buy) · derivative
|
2025-01-08 | Disposed to issuer | 240,721 | $0.00 | |
|
Poseida Therapeutics Inc PSTX
Employee Stock Option (Right to Buy) · derivative
|
2025-01-08 | Disposed to issuer | 172,600 | $0.00 | |
|
Poseida Therapeutics Inc PSTX
Employee Stock Option (Right to Buy) · derivative
|
2025-01-08 | Disposed to issuer | 48,115 | $0.00 | |
|
Poseida Therapeutics Inc PSTX
Employee Stock Option (Right to Buy) · derivative
|
2025-01-08 | Disposed to issuer | 518,500 | $0.00 | |
|
Poseida Therapeutics Inc PSTX
Employee Stock Option (Right to Buy) · derivative
|
2025-01-08 | Disposed to issuer | 364,060 | $0.00 | |
|
Poseida Therapeutics Inc PSTX
Common Stock
|
2025-01-02 | Tax withheld | 23,313 | $9.60 | 223,805 |
|
Poseida Therapeutics Inc PSTX
Employee Stock Option (Right to Buy) · derivative
|
2024-12-10 | Option exercise | 30,000 | $0.00 | |
|
Poseida Therapeutics Inc PSTX
Common Stock
|
2024-12-10 | Sell | 30,000 | $9.46 | 283,800 |
|
Poseida Therapeutics Inc PSTX
Common Stock
|
2024-12-10 | Option exercise | 30,000 | $2.78 | 83,400 |
|
Poseida Therapeutics Inc PSTX
Common Stock
|
2024-11-26 | Sell | 30,000 | $9.27 | 278,100 |
|
Poseida Therapeutics Inc PSTX
Common Stock
|
2024-11-26 | Option exercise | 30,000 | $2.78 | 83,400 |
|
Poseida Therapeutics Inc PSTX
Employee Stock Option (Right to Buy) · derivative
|
2024-11-26 | Option exercise | 30,000 | $0.00 | |
|
Poseida Therapeutics Inc PSTX
Common Stock
|
2024-03-01 | Tax withheld | 34,157 | $4.13 | 141,068 |
|
Poseida Therapeutics Inc PSTX
Common Stock
|
2024-02-01 | Tax withheld | 47,162 | $3.41 | 160,822 |
|
Poseida Therapeutics Inc PSTX
Common Stock
|
2024-01-02 | Grant | 125,000 | $0.00 | |
|
Poseida Therapeutics Inc PSTX
Stock Option (Right to buy) · derivative
|
2024-01-02 | Grant | 172,600 | $0.00 | |
|
Poseida Therapeutics Inc PSTX
Employee Stock Option (Right to Buy) · derivative
|
2023-03-01 | Grant | 364,060 | $0.00 | |
| showing 20 of 75 most recent transactions | |||||